News & Events

Press releases

Biotech Companies Seek to Restore Functions to Spinal-Cord Injury Patients

Stem cells, gene therapy among treatments under study for paralyzing injuries March 11, 2021:  Biotechnology companies and researchers are studying treatments that could help patients with spinal-cord injuries recover abilities to move and function that they have lost. Each year about 18,000 Americans suffer spinal-cord injuries, which are often caused

read more »

Novel drug regenerates erectile nerves damaged by prostate surgery

Researchers have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. The drug was tested in rats. New York, NY April 19, 2021:  Researchers at Albert Einstein College of Medicine have developed a topical

read more »

New Therapy for Corneal Burns

New York, NY February 3, 2021: In a study published online on January 8 in Translational Vision, Science and Technology, Albert Einstein College of Medicine scientists showed that their novel wound-healing therapy speeds the healing of corneal alkaline burns and may improve on current therapies that have limited success against

read more »

Upcoming events

Association for Research in Vision and Ophthalmology (ARVO) 2020 Annual Meeting

We look forward to sharing exciting data from our corneal burn program at ARVO.  Stay tuned for further details.

May 3-7, 2020
Baltimore, MD